Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis

BackgroundImmune checkpoint inhibitors (ICIs) have changed the treatment landscape of several cancer types. However, data are lacking with regard to the clinical responsiveness of ICIs in patients with advanced non-small cell lung cancer (NSCLC) after standard first-line chemotherapy. Therefore, we...

Full description

Bibliographic Details
Main Authors: Lupeng Qiu, Shan Gao, Sicheng Du, Shengjie Sun, Yanjie Liang, Zhuoya Sun, Tao Li, Guhe Jia, Ke Li, Xiaohui Sun, Shunchang Jiao, Xiao Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
immune checkpoint inhibitor
chemotherapy
propensity score matching
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.974227/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.974227/full

Similar Items